Trauma-focused therapy for older adults: A clinical case series

Not Applicable

• Conditions: Trauma-focused therapies to reduce post-traumatic stress symptoms; Mental and Behavioural Disorders

• Registration Number: ISRCTN51593856
• Lead Sponsor: niversity of Manchester

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-09
• Last Update Posted: 22 July 2024
• Study Completion: 2027-05-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

1. A probable PTSD/ complex PTSD according to the following thresholds:
1.1. At least one trauma event on the TALE
1.2. A probable diagnosis of PTSD or Complex PTSD as defined by the standard diagnostic algorithm for the ITQ (Cloitre et al., 2018)
1.3. A score of 31 or more on the PCL-5
2.Aged 60 years and above
3.Score of 22+ on the MOCA (Nasreddine et al., 2004).
4.Supported by an adult or an older adult community mental health team.
5.Capacity and willingness to provide informed consent.

Exclusion Criteria

1.Currently in a mental health crisis and/or actively suicidal
2.Insufficient English-language skills to comprehend the assessment and therapy content.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of the adapted trauma focused therapy intervention using the following metrics:<br>1.Individuals approached regarding the study measured using total numbers at the end of the recruitment period. <br>2.Individuals approached who are eligible and consent to take part in the study measured using total numbers at the end of the recruitment period. <br>3.Individuals approached who are eligible and do not take part in the study measured using total numbers at the end of the recruitment period.<br>4.Therapy sessions attended measured using total numbers at the end of the therapy sessions. <br>5.Participants who drop-out and at which point in the therapy measured using total numbers at the point of drop-out.<br>6.Adverse Events and Serious Adverse Events measured using total numbers at the end of the follow-up period.